Monthly Archives: February 2026

Ocumetics Announces Forbearance Agreement for $4 Million Secured Convertible Debentures and Provides LIFE Offering Update

Calgary, Alberta – February 10, 2026 – TheNewswire - Ocumetics Technology Corp. (“Ocumetics” or the “Corporation”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) is pleased to announce that the Corporation has entered into a forbearance agreement with the holders of secured convertible debentures (the “Debentures”) that were issued by the Corporation in May and June 2024 (see press release

By |2026-02-10T22:07:56+00:00February 10th, 2026|News|Comments Off on Ocumetics Announces Forbearance Agreement for $4 Million Secured Convertible Debentures and Provides LIFE Offering Update

Ocumetics Reports Positive Three Month First-in-Human Results, Significantly De-Risking Its Accommodating Intraocular Lens Technology

Key Highlights   Positive First-in-Human Results: Three-month Group 1 data met or exceeded expectations for safety, lens delivery, and vision performance.   Major De-Risking Milestone: The study successfully validated the core technology and cleared the path to the next clinical phase. Life-Changing Vision Improvements: Patients with severe vision loss experienced meaningful improvements in everyday

By |2026-02-03T15:30:35+00:00February 3rd, 2026|News|Comments Off on Ocumetics Reports Positive Three Month First-in-Human Results, Significantly De-Risking Its Accommodating Intraocular Lens Technology
Go to Top